Astrocytoma Grade Iv
📧 Sign up to get email alerts when something new happens for Astrocytoma Grade Iv.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma [Phase 1]
Phase 1 dose-escalation trial of re-irradiation in good-prognosis recurrent glioblastoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma [Phase 1]
Phase 1 clinical trial evaluating mycophenolate mofetil in combination with radiation therapy for glioblastoma and related astrocytomas; the…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Immunogenicity of EGFR(V)-EDV-Dox in Subjects With Recurrent GBM [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, and immunogenicity of EGFR(V)-EDV-Dox in subjects with recurrent glioblastoma and Grade…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Neural Stem Cell Based Virotherapy of Newly Diagnosed Malignant Glioma [Phase 1]
Phase 1 trial update of neural stem cell–based virotherapy for newly diagnosed malignant glioma; study completed with results posted in 2023…
-
CLINICAL_TRIALS trial_result · 2022-02-01Clinical Trial Update: DC Migration Study for Newly-Diagnosed GBM [Phase 2]
Phase 2 clinical trial update on dendritic cell migration for newly diagnosed glioblastoma; study completed with results posted in 2022.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-11-17Clinical Trial Update: Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma [Phase 1]
The Phase 1 trial of a neoepitope-based personalized vaccine for newly diagnosed glioblastoma was terminated.